Viewing Study NCT00700258


Ignite Creation Date: 2025-12-25 @ 12:11 AM
Ignite Modification Date: 2026-01-11 @ 11:01 AM
Study NCT ID: NCT00700258
Status: COMPLETED
Last Update Posted: 2024-09-23
First Post: 2008-06-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 3066K1-4407
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators